-
Je něco špatně v tomto záznamu ?
Bridging structural and functional biomarkers in functional movement disorder using network mapping
P. Sojka, M. Slovák, G. Věchetová, R. Jech, DL. Perez, T. Serranová
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-09-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Health & Medicine (ProQuest)
od 2011-09-01
Psychology Database (ProQuest)
od 2011-09-01
Wiley Free Content
od 2011
Wiley-Blackwell Open Access Titles
od 2011
ROAD: Directory of Open Access Scholarly Resources
od 2011
PubMed
35429407
DOI
10.1002/brb3.2576
Knihovny.cz E-zdroje
- MeSH
- biologické markery MeSH
- dyskineze * MeSH
- konektom * MeSH
- konverzní poruchy * MeSH
- lidé MeSH
- magnetická rezonanční tomografie MeSH
- mapování mozku MeSH
- mozek diagnostické zobrazování MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
BACKGROUND: There are gaps in our neurobiological understanding of functional movement disorder (FMD). OBJECTIVES: We investigated gray matter volumetric profiles in FMD, and related findings to resting-state functional connectivity (rsFC) profiles using Human Connectome Project data. METHODS: Volumetric differences between 53 FMD patients and 50 controls were examined, as well as relationships between individual differences in FMD symptom severity and volumetric profiles. Atrophy network mapping was also used to probe whether FMD-related structural alterations preferentially impacted brain areas with dense rsFC. RESULTS: Compared to controls without neurological comorbidities (albeit with mild depression and anxiety as a group), the FMD cohort did not show any volumetric differences. Across patients with FMD, individual differences in symptom severity negatively correlated with right supramarginal and bilateral superior temporal gyri volumes. These findings remained significant adjusting for FMD subtype or antidepressant use, but did not remain statistically significant adjusting for depression and anxiety scores. Symptom severity-related structural alterations mapped onto regions with dense rsFC-identifying several disease epicenters in default mode, ventral attention, and salience networks. CONCLUSIONS: This study supports that FMD is a multinetwork disorder with an important role for the temporoparietal junction and its related connectivity in the pathophysiology of this condition. More research is needed to explore the intersection of functional neurological symptoms and mood.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22018525
- 003
- CZ-PrNML
- 005
- 20220804134831.0
- 007
- ta
- 008
- 220720s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/brb3.2576 $2 doi
- 035 __
- $a (PubMed)35429407
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Sojka, Petr $u Department of Psychiatry, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic $1 https://orcid.org/0000000275947093
- 245 10
- $a Bridging structural and functional biomarkers in functional movement disorder using network mapping / $c P. Sojka, M. Slovák, G. Věchetová, R. Jech, DL. Perez, T. Serranová
- 520 9_
- $a BACKGROUND: There are gaps in our neurobiological understanding of functional movement disorder (FMD). OBJECTIVES: We investigated gray matter volumetric profiles in FMD, and related findings to resting-state functional connectivity (rsFC) profiles using Human Connectome Project data. METHODS: Volumetric differences between 53 FMD patients and 50 controls were examined, as well as relationships between individual differences in FMD symptom severity and volumetric profiles. Atrophy network mapping was also used to probe whether FMD-related structural alterations preferentially impacted brain areas with dense rsFC. RESULTS: Compared to controls without neurological comorbidities (albeit with mild depression and anxiety as a group), the FMD cohort did not show any volumetric differences. Across patients with FMD, individual differences in symptom severity negatively correlated with right supramarginal and bilateral superior temporal gyri volumes. These findings remained significant adjusting for FMD subtype or antidepressant use, but did not remain statistically significant adjusting for depression and anxiety scores. Symptom severity-related structural alterations mapped onto regions with dense rsFC-identifying several disease epicenters in default mode, ventral attention, and salience networks. CONCLUSIONS: This study supports that FMD is a multinetwork disorder with an important role for the temporoparietal junction and its related connectivity in the pathophysiology of this condition. More research is needed to explore the intersection of functional neurological symptoms and mood.
- 650 _2
- $a biologické markery $7 D015415
- 650 _2
- $a mozek $x diagnostické zobrazování $7 D001921
- 650 _2
- $a mapování mozku $7 D001931
- 650 12
- $a konektom $7 D063132
- 650 12
- $a konverzní poruchy $7 D003291
- 650 12
- $a dyskineze $7 D020820
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a magnetická rezonanční tomografie $7 D008279
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Slovák, Matěj $u Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000320235862
- 700 1_
- $a Věchetová, Gabriela $u Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000327916388
- 700 1_
- $a Jech, Robert $u Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000297328947 $7 xx0082225
- 700 1_
- $a Perez, David L $u Functional Neurological Disorder Unit, Cognitive Behavioral Neurology Division, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA $u Division of Neuropsychiatry, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA $u Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, USA $1 https://orcid.org/000000032721583X
- 700 1_
- $a Serranová, Tereza $u Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000165253971 $7 xx0128890
- 773 0_
- $w MED00188000 $t Brain and behavior $x 2162-3279 $g Roč. 12, č. 5 (2022), s. e2576
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35429407 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804134824 $b ABA008
- 999 __
- $a ok $b bmc $g 1822221 $s 1169768
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 12 $c 5 $d e2576 $e 20220416 $i 2162-3279 $m Brain and behavior $n Brain Behav $x MED00188000
- LZP __
- $a Pubmed-20220720